There are 10 ASEs presented in all three subgroups (Fig. 2f) which were considered to be the PTEN-regulated ASEs most relevant to cancers, and all of which show negative correlation with patient survival (Fig. 2g and Supplementary Fig. 1B). The gene discussed is PTEN; the disease is cancer.